Cold Plasma in Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Wound Healing, Surgical Application and Other Medical Applications), By Region and Competition, 2020-2030F

Market Overview

Global Cold Plasma in Healthcare Market was valued at USD 2.14 Billion in 2024 and is expected to reach USD 4.25 Billion by 2030 with a CAGR of 12.11% during the forecast period. The Cold Plasma in Healthcare market is a dynamic and rapidly evolving sector within the broader healthcare industry. It encompasses the application of cold plasma technology for various medical purposes, including wound healing, cancer treatment, sterilization, and dermatology. What sets cold plasma apart is its non-invasive and non-thermal nature, making it a versatile tool in medical settings. Its ability to stimulate tissue regeneration, promote angiogenesis, and eradicate pathogens without harming healthy tissues has garnered significant attention from healthcare providers, researchers, and industry players.

According to research by the University of Michigan, cold plasma is the most effective solution for removing dangerous airborne viruses. Non-thermal plasma can remove up to 99% of the virus in fractions of seconds. This creates opportunities for doctors to treat patients with breathing problems using cold plasma technologies. In recent years, the market has witnessed substantial growth, driven by the increasing prevalence of chronic diseases, such as diabetes and cancer, which demand innovative and efficient treatment solutions. Cold plasma's efficacy in wound care, where chronic wounds like diabetic ulcers pose a substantial healthcare challenge, positions it as a frontrunner in addressing these unmet medical needs. Moreover, the global emphasis on infection control and patient safety, particularly in the wake of the COVID-19 pandemic, has accelerated the adoption of cold plasma technology for sterilization and decontamination purposes.

 The cold plasma healthcare market is witnessing remarkable technological advancements driven by increased research and development efforts. In July 2023, a pioneering collaboration between Queen's University and Thomas Jefferson University introduced an innovative approach to enhancing antibiotic efficacy using atmospheric pressure plasma. This breakthrough holds significant potential for combating antibiotic-resistant bacterial infections, showcasing the expanding capabilities of cold plasma technology. Additionally, the industry has seen a surge in research initiatives, with numerous institutions worldwide exploring novel applications in plasma medicine, particularly in infection control and tissue regeneration.

Key Market Drivers

Increasing Chronic Diseases

The increasing prevalence of chronic diseases, such as diabetes and cancer, is a pivotal factor driving the growth of the Cold Plasma in Healthcare market. Chronic diseases have become a global health epidemic, imposing significant burdens on healthcare systems and patients alike. Cold plasma technology has emerged as a promising solution to address some of the challenges associated with the management and treatment of these conditions. According to WHO, Noncommunicable diseases (NCDs) killed at least 43 million people in 2021, equivalent to 75% of non-pandemic-related deaths globally. In 2021, 18 million people died from an NCD before age 70 years; 82% of these premature deaths occur in low- and middle-income countries. Of all NCD deaths, 73% are in low- and middle-income countries. Cardiovascular diseases account for most NCD deaths, or at least 19 million deaths in 2021, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes (over 2 million including kidney disease deaths caused by diabetes). These four groups of diseases account for 80% of all premature NCD deaths.

One of the primary applications of cold plasma in the context of chronic diseases is in wound healing, particularly for individuals with diabetes. Diabetic ulcers, often slow to heal and prone to complications, are a common consequence of the disease. Cold plasma's ability to stimulate cell proliferation and angiogenesis plays a critical role in expediting the healing process for such chronic wounds. By enhancing tissue regeneration and reducing infection risk, cold plasma therapy offers hope to individuals suffering from diabetes-related ulcers, improving their quality of life and potentially preventing more severe complications like limb amputations. Moreover, the prevalence of cancer is on the rise globally, and traditional treatment modalities like chemotherapy and radiation therapy can be invasive and debilitating. Cold plasma technology has shown promise in the selective targeting and destruction of cancer cells while sparing healthy tissue. This approach not only improves the effectiveness of cancer treatment but also minimizes side effects, enhancing the overall patient experience.

Rising Healthcare Awareness

The factor of "Rising Healthcare Awareness" plays a crucial role in the growth and evolution of the Cold Plasma in the Healthcare market. Over the past few years, there has been a notable shift in healthcare awareness among both healthcare providers and patients, leading to increased recognition of the potential benefits and applications of cold plasma technology.

Firstly, healthcare providers are becoming more aware of the diverse applications of cold plasma in various medical fields. They are recognizing its potential to revolutionize practices in sterilization, wound healing, cancer treatment, dermatology, and beyond. This heightened awareness has prompted healthcare institutions to invest in research and development, clinical trials, and the integration of cold plasma devices into their treatment protocols. As a result, the adoption of cold plasma technology has gained traction within healthcare settings.

Secondly, patients are increasingly informed about alternative and innovative treatment options, thanks to the proliferation of healthcare information through the internet and social media. This has led to a growing demand for non-traditional, cutting-edge therapies that offer better outcomes and improved patient experiences. As patients become more proactive in managing their health, they are seeking out healthcare providers who offer advanced treatments, including those based on cold plasma technology.

Additionally, the COVID-19 pandemic played a significant role in raising healthcare awareness regarding the importance of infection control and patient safety. Cold plasma's effectiveness in quickly and safely sterilizing surfaces and equipment became evident during the pandemic, further highlighting its relevance and prompting healthcare facilities to consider its adoption.

Download Free Sample Report

Key Market Challenges

Integration into Healthcare Workflows

Challenge facing the Cold Plasma in Healthcare market is the integration of cold plasma devices into existing healthcare workflows. While the technology holds immense promise, seamlessly incorporating it into the routines and practices of healthcare facilities presents several complexities. Healthcare institutions operate within well-established protocols and procedures, and any introduction of new technology must align with these workflows to ensure efficiency and effectiveness. The challenges of integration primarily revolve around the following aspects:

Firstly, healthcare facilities need to invest in the necessary infrastructure to accommodate cold plasma devices. This includes considerations such as space allocation, electrical requirements, and the integration of cold plasma equipment with existing medical equipment and systems. These changes can be resource-intensive and require careful planning.

Secondly, staff training is paramount. Healthcare professionals, from nurses to technicians and physicians, need to be proficient in operating and maintaining cold plasma devices. Training programs must be developed and implemented, and ongoing education is essential to keep healthcare providers updated on best practices.

Thirdly, the introduction of new technology can disrupt established workflows. Healthcare institutions must carefully manage this transition to minimize disruptions to patient care. This may involve temporarily parallel processes or gradual integration to ensure a smooth shift.

Lastly, there is a cost associated with the integration of cold plasma technology. Healthcare facilities must allocate budgets for equipment acquisition, staff training, and infrastructure improvements. This financial commitment can be a significant hurdle for some institutions, particularly smaller healthcare providers.

Cost of Implementation

Challenge in the Cold Plasma in Healthcare market is the cost of implementation. While the benefits of cold plasma technology are increasingly recognized, the initial financial investment required for its acquisition, integration, and operation can be a significant barrier for healthcare providers and institutions. Firstly, the upfront cost of purchasing cold plasma equipment can be substantial. High-quality cold plasma devices are precision instruments with advanced technology, which often comes with a corresponding price tag. Smaller healthcare facilities or those with limited budgets may find it challenging to allocate resources for the initial purchase.

Secondly, beyond the acquisition cost, ongoing operational expenses must be considered. This includes maintenance, calibration, and regular servicing of the cold plasma devices to ensure they function optimally. Additionally, the cost of consumables, such as gas supplies, may add to the overall cost of implementation. Furthermore, investments in infrastructure and facilities may be necessary to accommodate cold plasma technology. Modifications to existing healthcare environments to meet the electrical and spatial requirements of cold plasma equipment can contribute to the financial burden. Healthcare providers must also allocate resources for staff training and education. Ensuring that healthcare professionals are proficient in using and maintaining cold plasma devices is essential for safe and effective operation.

Key Market Trends

Data-Driven Healthcare

Key trend in the Cold Plasma in Healthcare market centers around data-driven healthcare. This trend is marked by the integration of cold plasma devices with advanced data collection and analysis systems to enhance treatment precision and effectiveness. In today's healthcare landscape, data is king. Cold plasma technology is no exception. Manufacturers are incorporating sensors and monitoring capabilities into cold plasma devices, allowing for real-time data collection during treatments. This data can include parameters like temperature, gas flow rates, and treatment duration. The information collected is then transmitted to centralized systems or cloud platforms, where it can be analyzed and interpreted.

The advantages of data-driven healthcare with cold plasma are significant. It enables healthcare providers to closely monitor and adjust treatments based on patient-specific data, optimizing therapeutic outcomes. For example, in wound healing, data-driven systems can assess tissue response to cold plasma treatment and make real-time adjustments to promote faster healing. In cancer treatment, treatment efficacy can be closely monitored, ensuring that the cold plasma precisely targets cancer cells while sparing healthy tissue.

Furthermore, the collected data can contribute to research and development efforts, facilitating continuous improvement in cold plasma technology and its applications in healthcare. It also supports evidence-based decision-making, which is crucial for gaining regulatory approvals and building trust among healthcare professionals. This trend aligns with the broader movement toward digitalization in healthcare, offering increased treatment precision, patient safety, and the potential for more effective, personalized medical care. As data-driven approaches become more prevalent, they are expected to further solidify the role of cold plasma technology as a valuable tool in modern healthcare practices.

Personalized Medicine

Personalized medicine, within the context of the healthcare market, represents a transformative approach to patient care and treatment that tailors medical interventions to individual characteristics, needs, and genetic profiles. This trend is reshaping the Cold Plasma in Healthcare market by emphasizing precision and customization in the delivery of healthcare solutions. In personalized medicine, treatments and therapies are designed to align precisely with a patient's unique genetic makeup and medical history. This approach allows for more targeted and effective interventions, reducing the risk of adverse effects and optimizing therapeutic outcomes. For the Cold Plasma in Healthcare market, this means that cold plasma technology can be fine-tuned to suit the specific requirements of each patient, whether it's in wound healing, cancer treatment, or other applications. The demand for personalized medicine is on the rise as patients and healthcare providers increasingly seek treatments that are not only effective but also minimize side effects and maximize the likelihood of success. Cold plasma's adaptability and versatility make it well-suited to this trend, as it can be adjusted and optimized for individual patient needs. Furthermore, personalized medicine has the potential to drive research and development in the Cold Plasma in Healthcare market. As more data is collected on patient outcomes and treatment responses, it can inform the refinement of cold plasma technologies and their applications, resulting in more effective and patient-centric solutions.

Segmental Insights

Application Insights

Based on the Application, the Wound Healing Segment dominated the Cold Plasma in Healthcare market and is predicted to continue expanding over the coming years. The dominance of the Wound Healing Segment in the Cold Plasma in Healthcare market can be attributed to several compelling factors, making it a frontrunner with continued expansion prospects. Firstly, chronic wounds, such as diabetic ulcers and pressure sores, pose a growing healthcare challenge globally. These conditions demand innovative and effective wound care solutions, and cold plasma technology has emerged as a promising answer. Cold plasma accelerates wound healing by stimulating cell proliferation, angiogenesis, and tissue regeneration while minimizing infection risk. This exceptional therapeutic capacity has garnered significant attention from healthcare providers and researchers. Secondly, as healthcare systems worldwide seek cost-effective and efficient solutions, the role of cold plasma in wound care gains prominence. By expediting the healing process and reducing the risk of complications, it not only improves patient outcomes but also contributes to cost savings in the long run. Healthcare institutions are increasingly recognizing the economic benefits of implementing cold plasma devices. Moreover, the COVID-19 pandemic underscored the importance of maintaining sterile healthcare environments and efficient wound care, further amplifying the demand for cold plasma solutions. Hospitals and clinics sought effective means of infection control and wound treatment, making cold plasma technology a critical asset in the healthcare landscape.

Download Free Sample Report

Regional Insights

Based on the Region, the North America region has established itself as the leader in the Cold Plasma in Healthcare Market in 2024. Firstly, North America boasts a robust and well-established healthcare infrastructure, which includes cutting-edge medical facilities, research institutions, and a technologically advanced healthcare sector. This provides a conducive environment for the adoption and integration of innovative technologies like cold plasma into mainstream healthcare practices. Secondly, the region's heightened awareness of healthcare advancements and the importance of patient safety has driven the rapid adoption of cold plasma technology. Healthcare providers in North America are increasingly recognizing the benefits of cold plasma in sterilization, wound healing, and cancer treatment, particularly in the context of the COVID-19 pandemic. This has led to a surge in demand for cold plasma devices. Thirdly, North America's regulatory environment, while stringent, provides clear pathways for the approval and deployment of medical technologies. Regulatory agencies like the FDA in the United States have been actively engaged in assessing and approving cold plasma devices, giving healthcare providers confidence in their safety and efficacy. Moreover, collaborations between academia, industry, and healthcare providers in North America have fostered innovation and knowledge sharing, facilitating the development and implementation of cold plasma technology in diverse medical specialties. 

Germany is witnessing significant growth in the cold plasma healthcare market, driven by advancements in medical technology, increasing research activities, and rising demand for non-invasive therapeutic solutions. The country is at the forefront of plasma medicine innovations, with several universities and research institutes actively exploring the applications of cold plasma in wound healing, infection control, and cancer therapy. On the other hand, road traffic accidents remain one of the leading causes of trauma, and utilization of cold plasma in hospitals and healthcare organizations is likely to increase. With more than 21 million seniors projected to live in Germany by 2040 (Germany Federal Statistical Office, 2020), the demand for the development of effective wound management solutions will increase with this population. Among the numerous treatment modalities developed and available, cold plasma represents one of the most promising options for chronic wounds.

Recent Developments

• In February 2024, Adtec Healthcare visited Taiwan to advance its SteriPlas expansion project, focusing on enhancing cold plasma technology for sterilization applications. This initiative aims to strengthen Adtec's footprint in the Asian market, catering to the rising demand for innovative healthcare solutions. The expansion underscores the company's commitment to improving healthcare standards through advanced sterilization techniques and strategic technology partnerships.
• In September 2023, researchers at IIT Jodhpur developed the Novel Cold-Plasma Detergent in Environment (CODE) device, designed to improve indoor air quality by deactivating over 99.99% of harmful pathogens. This cutting-edge technology tackles major concerns related to air pollution, particularly in indoor spaces. The CODE device, which integrates non-equilibrium cold plasma and nanotechnology, is expected to play a vital role in reducing airborne infections and is set for commercial release in the near future.
• In August 2023, the Jerome Canady Research Institute (JCRI) and U.S. Medical Innovations (USMI) successfully completed an FDA Phase 1 clinical trial using Canady Helios Cold Plasma (CHCP) in combination with tumor resection. This innovative technique effectively targeted and eliminated cancer cells at the surgical margin while preserving healthy tissue. The approach demonstrated promising outcomes, including reduced local recurrence, enhanced overall survival rates, and the potential to eradicate residual cancer cells post-surgery.
• In March 2022, Neoplas Med GmbH unveiled the results of a gold standard clinical trial, showcasing the effectiveness of their cold atmospheric plasma beam therapy in the management of chronic wounds. This comparative clinical study highlighted substantial enhancements in wound closure rates and infection control when utilizing Neoplas Med's plasmajet kINPen MED, outperforming conventional wound care approaches.
• In September 2021, US Medical Innovations, LLC (USMI), a reputable United States-based life sciences and biomedical device company with FDA registration, along with the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS), disclosed positive outcomes from a Phase I clinical trial. This trial showcased the application of cold atmospheric plasma for the treatment of solid tumors, and the results were presented at the Baird 2021 Global Healthcare Conference.

Key Market Players

• Neoplas med GmbH
• U.S. Medical Innovations
• Terumo Medical Corp
• Adtec Plasma Technology Co Ltd
• Apyx Medical Corp
• Nordson Corp
• Europlasma NV
• Terraplasma GmbH
• Henniker Plasma
• Smith & Nephew plc

Report Scope:

In this report, the Cold Plasma in Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Cold Plasma in Healthcare Market, By Application:
• Wound Healing
• Surgical Application
• Other Medical Applications
• Cold Plasma in Healthcare Market, By Region:
• North America

o   United States

o   Canada

o   Mexico

• Europe

o   Germany

o   United Kingdom

o   Italy

o   France

o   Spain

• Asia Pacific

o   China

o   India

o   Japan

o   South Korea

o   Australia

• South America

o   Brazil

o   Argentina

o   Colombia

• Middle East & Africa

o   South Africa

o   Saudi Arabia

o   UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Cold Plasma in Healthcare Market.

Available Customizations:

Cold Plasma in Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Cold Plasma in Healthcare Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]